Edge Pharma, LLC recalls Moxifloxacin, Sterile Ophthalmic Solution for Injection, Preservative Free, 0.8mg/0.8 mL (1mg/mL), 0.8 mL per syringe, S
Recalled February 2, 2022 · FDA recall D-0410-2022 · Edge Pharma
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
860 syringes
Sold at
nationwide
Description
Lack of Assurance of Sterility
Product
Moxifloxacin, Sterile Ophthalmic Solution for Injection, Preservative Free, 0.8mg/0.8 mL (1mg/mL), 0.8 mL per syringe, Single Use Syringe, For Intraocular Injection, Edge Pharma, LL, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1050-01
Manufacturer(s)
Edge Pharma, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →